Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Bacterial Infections and Mycoses

Free Subscription 09.02.2026 23 Antimicrob Agents Chemother 1 Biochemistry 2 BMC Pediatr 13 Clin Infect Dis 3 Curr Microbiol 2 Diagn Microbiol Infect Dis 15 Eur J Clin Microbiol Infect Dis 2 Infect Immun 6 J Antimicrob Chemother 1 J Bacteriol 2 J Biol Chem 3 J Clin Invest 1 J Immunol 2 J Infect Dis 1 J Med Chem 2 J Med Microbiol 1 JAMA 1 Pediatrics 5 PLoS Biol 1 PLoS Med 4 PLoS Negl Trop Dis 12 PLoS One 2 PLoS Pathog 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. ALHOTHALI MT, Seemann T, Andersson P, Sherry N, et al
   Rising burden of enterococcal bacteremia in Victoria, Australia: population-based incidence and antimicrobial resistance trends from three decades of surveillance.
   Antimicrob Agents Chemother. 2026 Feb 4:e0152625. doi: 10.1128/aac.01526.
   PubMed         Abstract available
   
   
2. SONG Y, Buil JB, Zoll J, Tehupeiory-Kooreman M, et al
   Characteristics of individual cyp51A SNPs and combinations thereof impacting the azole phenotype in TR(34)-mediated resistance genotypes of Aspergillus fumigatus.
   Antimicrob Agents Chemother. 2026 Feb 3:e0152825. doi: 10.1128/aac.01528.
   PubMed         Abstract available
   
   
3. LEPAK A, Bhavnani SM, Castanheira M, Rubino CM, et al
   Evaluation of an in vivo pulmonary aspergillosis model for triazole susceptibility breakpoint development.
   Antimicrob Agents Chemother. 2026 Jan 30:e0164325. doi: 10.1128/aac.01643.
   PubMed         Abstract available
   
   
4. WANG J, Paroha R, Sha J, Verma AK, et al
   Protective mechanism of action of the antifungal drug naftifine against Mycobacterium abscessus infection.
   Antimicrob Agents Chemother. 2026;70:e0110525.
   PubMed         Abstract available
   
   
5. SHAO Y, Lan X, Zhang X, Wang L, et al
   fosZ, a novel plasmid-borne fosfomycin resistance gene in Pseudomonas species, especially carbapenem-resistant Pseudomonas aeruginosa isolates.
   Antimicrob Agents Chemother. 2026 Jan 14:e0075025. doi: 10.1128/aac.00750.
   PubMed         Abstract available
   
   
6. COLLINGS H, Stone M, Chrysostomou M, Hirst A, et al
   A systematic literature review and (network) meta-analysis of the effectiveness of ceftolozane/tazobactam versus aminoglycosides/polymyxins and ceftazidime/avibactam for treating adult patients with multidrug-resistant Pseudomonas aeruginosa infection
   Antimicrob Agents Chemother. 2026;70:e0073525.
   PubMed         Abstract available
   
   
7. WU Y, Han Q, Yang H, Xue J, et al
   Effects of renal impairment and hemodialysis on the pharmacokinetics and safety of HRS-8427, a siderophore cephalosporin for Gram-negative bacterial infections.
   Antimicrob Agents Chemother. 2026;70:e0109525.
   PubMed         Abstract available
   
   
8. SASSMAN M, Karolak M, Dallaire M, Schaffer CE, et al
   Beyond mecA: a two-tiered mechanism and regulatory rewiring drive high-level ceftaroline resistance in clinical MRSA.
   Antimicrob Agents Chemother. 2026;70:e0058625.
   PubMed         Abstract available
   
   
9. MOHAMMAD S, Al Namer Y, Rahimeh W, Albalas M, et al
   Effectiveness and safety of meropenem-vaborbactam versus ceftazidime-avibactam in multidrug-resistant Gram-negative infections: a systematic review and meta-analysis with trial sequential analysis.
   Antimicrob Agents Chemother. 2026;70:e0154625.
   PubMed         Abstract available
   
   
10. LLORENTE J, Sempere J, Llamosi M, Perez-Garcia C, et al
    Emergence of antibiotic-resistant pneumococcal serotypes causing invasive pneumococcal disease in children, Spain.
    Antimicrob Agents Chemother. 2025 Dec 31:e0153025. doi: 10.1128/aac.01530.
    PubMed         Abstract available
    
    
11. OMACHI R, Imai K, Sato A, Tanaka M, et al
    Spread of dual-class drug-resistant Mycoplasma genitalium in Tokyo, Japan, 2023-2025.
    Antimicrob Agents Chemother. 2026;70:e0136725.
    PubMed         Abstract available
    
    
12. LUO J, Liu M, Ai W, Zheng X, et al
    Gtr9 mutation trades phage resistance for carbapenem sensitivity to potentiate phage-meropenem therapy against carbapenem-resistant Acinetobacter baumannii in vitro.
    Antimicrob Agents Chemother. 2025 Dec 30:e0135525. doi: 10.1128/aac.01355.
    PubMed         Abstract available
    
    
13. FAN M, Zhang Z, Liu X, Deng L, et al
    Phylogenetic diversification and fitness trade-offs of TetA variants in mediating eravacycline resistance in Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2026;70:e0067125.
    PubMed         Abstract available
    
    
14. BONCOMPAGNI SR, Antonelli A, Casciato B, Pieralli F, et al
    NDM-63: a novel NDM metallo-beta-lactamase variant in the L3 loop, from a Klebsiella pneumoniae clinical isolate.
    Antimicrob Agents Chemother. 2026;70:e0128625.
    PubMed         Abstract available
    
    
15. SHAH S, Clarke LG, Falcione BA, Shields RK, et al
    Incidence and factors associated with rapid blood culture sterilization among patients receiving ertapenem combination therapy for MSSA bacteremia.
    Antimicrob Agents Chemother. 2026;70:e0130325.
    PubMed         Abstract available
    
    
16. BOSIRE EM, Rather MA, Bell KE, Pavinski Bitar PD, et al
    A recombinant lysogenic bacteriophage inhibits Salmonella virulence.
    Antimicrob Agents Chemother. 2026;70:e0134125.
    PubMed         Abstract available
    
    
17. BAEZ-BARROSO G-A, Rodriguez-Coello A, Vazquez-Ucha JC, Lopez-Arguello S, et al
    Antibacterial activity of enmetazobactam against Acinetobacter spp.: a molecular dissection of mechanism of action and resistance determinants.
    Antimicrob Agents Chemother. 2026;70:e0120625.
    PubMed         Abstract available
    
    
18. IRELAND RE, Nunez A, Butcher W, Davies C, et al
    Inhaled liposomal ciprofloxacin protects against lethal tularemia in the common marmoset.
    Antimicrob Agents Chemother. 2026;70:e0123225.
    PubMed         Abstract available
    
    
19. PARK J, Choi S, Jeon YR, Kim L-H, et al
    Evaluation of clofazimine-bedaquiline combination as a candidate regimen for macrolide-resistant Mycobacterium avium complex infection.
    Antimicrob Agents Chemother. 2025 Dec 19:e0151125. doi: 10.1128/aac.01511.
    PubMed         Abstract available
    
    
20. LAMONT EA, Kordus SL, Howe MD, Jia Z, et al
    Essential role of MHC II in the antitubercular efficacy of pyrazinamide.
    Antimicrob Agents Chemother. 2026;70:e0126425.
    PubMed         Abstract available
    
    
21. MAHADEVAN R, Garcia E, Sharma R, Qiu H, et al
    A mechanism-based pharmacokinetic/pharmacodynamic analysis of polymyxin B-based combination therapy against carbapenem-resistant Klebsiella pneumoniae isolates with diverse phenotypic and genotypic resistance mechanisms.
    Antimicrob Agents Chemother. 2025 Dec 19:e0078225. doi: 10.1128/aac.00782.
    PubMed         Abstract available
    
    
22. GUMBO T, Boorgula GD, Srivastava S
    Preclinical pharmacokinetics/pharmacodynamics studies defining the role of ethambutol in Mycobacterium kansasii lung disease.
    Antimicrob Agents Chemother. 2026;70:e0144725.
    PubMed         Abstract available
    
    
23. LOPEZ CL, Rerolle G, Snyder S, Arias O, et al
    An alveolar macrophage-targeted ciprofloxacin polymeric prodrug improves survival in a murine model of Klebsiella pneumoniae pneumonia.
    Antimicrob Agents Chemother. 2026;70:e0036325.
    PubMed         Abstract available
    
    

    
    Biochemistry

24. PRIYA M, de Carvalho LPS
    Circumnavigating Antibiotic Mechanisms of Action and Resistance Research.
    Biochemistry. 2026;65:249-262.
    PubMed         Abstract available
    
    

    
    BMC Pediatr

25. MA D, Xu S, Yu D, Peng A, et al
    Cytomegalovirus-induced severe enterocolitis associated with ANCA-associated vasculitis and diffuse alveolar haemorrhage in a child: a diagnostic and therapeutic dilemma.
    BMC Pediatr. 2026 Feb 5. doi: 10.1186/s12887-026-06578.
    PubMed        
    
    
26. XU Y, Dai YL, Lei H, Yuan YL, et al
    A study on the correlation between intestinal flora characteristics and serum zinc and iron levels in paediatric patients with mycoplasma pneumoniae pneumonia.
    BMC Pediatr. 2026;26:79.
    PubMed         Abstract available
    
    

    
    Clin Infect Dis

27. SOLERA JT, Aparicio-Minguijon E, Dominguez-Perez L, Munoz P, et al
    Baseline Antithrombotic Therapy and Intracranial Hemorrhage Risk in Infective Endocarditis: A Multicenter Prospective Cohort Study.
    Clin Infect Dis. 2026 Feb 6:ciag067. doi: 10.1093.
    PubMed         Abstract available
    
    
28. FLORES JM, Rochat R, Stafford IA, Heiselman C, et al
    State-of-the-Art Review: Congenital Syphilis in the Modern Era: Current Strategies and Future Directions.
    Clin Infect Dis. 2026;81:1023-1035.
    PubMed         Abstract available
    
    
29. SOLOVYEVA AV, Volchenkov GV, Ponomarenko OI, Kuznezova TA, et al
    Implementing a Program of Comprehensive Tuberculosis Preventive Treatment: Safety, Effectiveness, and Acceptability of Moxifloxacin or Bedaquiline Use for Contacts Exposed to Drug-Resistant Strains.
    Clin Infect Dis. 2026 Feb 3:ciaf701. doi: 10.1093.
    PubMed         Abstract available
    
    
30. MANZOOR F, Rhee C, Baker MA, Klompas M, et al
    Mycobacterium tuberculosis Transmission in Healthcare Settings: A Systematic Review of Frequency, Risk Factors, and Exposure Conditions.
    Clin Infect Dis. 2026 Jan 30:ciag053. doi: 10.1093.
    PubMed         Abstract available
    
    
31. BROWN L, Hoa NT, Ly VT, Li L, et al
    Recent Advances in the Diagnosis of Talaromycosis.
    Clin Infect Dis. 2026;81:e533-e543.
    PubMed         Abstract available
    
    
32. WANG C, LaBere BA, Chinga MML, Harris AJ, et al
    Interferon-gamma Therapy in Patients With Refractory Disseminated Coccidioidomycosis.
    Clin Infect Dis. 2026;81:e544-e547.
    PubMed         Abstract available
    
    
33. BAKER AW, La Hoz RM, Anesi JA, Kwon JH, et al
    Epidemiology of Healthcare Facility-Associated Nontuberculous Mycobacteria From 2012 Through 2020 in a 10-Hospital Network in the United States.
    Clin Infect Dis. 2026;81:1106-1114.
    PubMed         Abstract available
    
    
34. SWARTWOOD NA, Cohen T, Marks SM, Hill AN, et al
    Effects of the COVID-19 pandemic on TB outcomes in the United States: a Bayesian analysis.
    Clin Infect Dis. 2025 Feb 27:ciaf092. doi: 10.1093.
    PubMed         Abstract available
    
    
35. BENEDICT K, Hennessee I, Smith DJ, Toda M, et al
    Impact of Fluconazole on Outcomes of Patients With Primary Pulmonary Coccidioidomycosis: A Commercial Health Insurance Claims-based, Propensity Score Matched Analysis.
    Clin Infect Dis. 2026;81:e515-e522.
    PubMed         Abstract available
    
    
36. FALLY M, Bastrup Israelsen S, Benfield T, Tarp B, et al
    The Impact of Lower Respiratory Tract Sample Cultures on Outcomes in Community-Acquired Pneumonia: A Propensity Score-Matched Cohort Study.
    Clin Infect Dis. 2026;81:1152-1158.
    PubMed         Abstract available
    
    
37. MUNRO AP, House T
    Cycles of susceptibility: Immunity debt explains altered infectious disease dynamics post -pandemic.
    Clin Infect Dis. 2024 Oct 11:ciae493. doi: 10.1093.
    PubMed         Abstract available
    
    
38. HIRUY H, Bala S, Byrne JM, Roche KG, et al
    FDA, CDC, and NIH Co-sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea.
    Clin Infect Dis. 2024 Jul 24:ciae386. doi: 10.1093.
    PubMed         Abstract available
    
    
39. MOHAREB AM, Barshak MB, Papaliodis GN, Sobrin L, et al
    Ocular syphilis in patients with nonreactive RPR and positive treponemal serologies: a retrospective observational cohort study.
    Clin Infect Dis. 2024 Jul 2:ciae354. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Curr Microbiol

40. HAROUNI NAVROUDI F, Kouchakinejad R, Bazri Chenijani A, Kouhsari Chalehsarayi S, et al
    Synergistic Antibacterial Activity of Quercetin-Functionalized Magnetic Nanoparticles Combined with Ciprofloxacin on Pathogenic Pseudomonas Aeruginosa Via Targeting Virulence, Efflux Pump, and Adhesion-Associated Genes and Molecular Docking Analysis.
    Curr Microbiol. 2026;83:159.
    PubMed         Abstract available
    
    
41. FANG C, Zhou Z, Zhang X, Xia J, et al
    Epidemiological and Genomic Insights into Linezolid-Non-Susceptible Enterococci in Pediatric Patients.
    Curr Microbiol. 2026;83:155.
    PubMed         Abstract available
    
    
42. PRAKASH S, Kumar A, Kumari H, Sinha M, et al
    In-Silico and Functional Characterization of EcdLp, an ABC Transporter of Aspergillus nidulans NRRL11440.
    Curr Microbiol. 2026;83:149.
    PubMed         Abstract available
    
    

    
    Diagn Microbiol Infect Dis

43. AL-JANABI AAHS
    Pathogenic Candida as a supplementary nutrient for dermatophytes.
    Diagn Microbiol Infect Dis. 2026;115:117285.
    PubMed         Abstract available
    
    
44. MICHENI LN, Wambua S, Magutah K, Nkaiwuatei J, et al
    Bridging the implementation gap: Challenges and opportunities for integrating whole genome sequencing in tuberculosis surveillance in low-resource settings.
    Diagn Microbiol Infect Dis. 2026;115:117282.
    PubMed         Abstract available
    
    

    
    Eur J Clin Microbiol Infect Dis

45. WELLINGHAUSEN N, Deininger S, Frodl R, Voss M, et al
    Upsurge of Chlamydia pneumoniae respiratory tract infections in 2024/2025 in Southern Germany.
    Eur J Clin Microbiol Infect Dis. 2026 Jan 31. doi: 10.1007/s10096-026-05419.
    PubMed         Abstract available
    
    
46. SFACIOTTE RAP, Carniel F, Parussolo L, Traverso SD, et al
    Fatal necrotizing fasciitis in a dog caused by NDM-producing extensively drug-resistant Acinetobacter baumannii: a case report.
    Eur J Clin Microbiol Infect Dis. 2026;45:297-301.
    PubMed         Abstract available
    
    
47. AKTER T, Challita PM, Haider AM, Islam S, et al
    Structural and functional insights into Pseudomonas aeruginosa's secretion systems 1-6: regulation, role in microbial keratitis and drug targets.
    Eur J Clin Microbiol Infect Dis. 2026;45:79-101.
    PubMed         Abstract available
    
    
48. KANG X, Gou L, Chen X, Wang Y, et al
    Application value and performance of stool antigen detection in the diagnosis of Helicobacter pylori infection.
    Eur J Clin Microbiol Infect Dis. 2026;45:69-77.
    PubMed         Abstract available
    
    
49. HARI MB, Sreelekshmi AL, Babu P, Jaykumar AP, et al
    Novel bacteriophages effectively target multidrug-resistant clinical isolates of Klebsiella pneumoniae.
    Eur J Clin Microbiol Infect Dis. 2026;45:271-286.
    PubMed         Abstract available
    
    
50. AYDEMIR O, Misi BE, Erdal H, Arican M, et al
    Evaluation of VITEK 2 and three protocols for direct susceptibility testing on Gram-negative bacilli from positive blood culture bottles.
    Eur J Clin Microbiol Infect Dis. 2026;45:235-246.
    PubMed         Abstract available
    
    
51. SARMAST M, Peeri-Dogaheh H, Karami C, Khademi F, et al
    Isolation and characterization of a lytic phage and its efficacy against multi-drug resistant strains of pseudomonas aeruginosa.
    Eur J Clin Microbiol Infect Dis. 2026;45:217-225.
    PubMed         Abstract available
    
    
52. BHAT A, Mansoor A, Fatima M, Kumar A, et al
    Safety and efficacy of fecal microbiota transplantation versus antibiotics for treating clostridioides difficile infection: systematic review and meta-analysis.
    Eur J Clin Microbiol Infect Dis. 2026;45:57-68.
    PubMed         Abstract available
    
    
53. OLSSON A, Rafeletou A, Aman A, Athanasiou N, et al
    Multicenter evaluation of the QuickMIC((R)) rapid AST system in clinical practice: impact on turnaround time compared to routine AST systems.
    Eur J Clin Microbiol Infect Dis. 2026;45:185-196.
    PubMed         Abstract available
    
    
54. GIBERT C, Rasigade JP, Salka W, Roussel-Gaillard T, et al
    Adaptation and performance evaluation of the French society of microbiology algorithm for detection of carbapenemase-producing enterobacterales using VITEK2 antibiotic susceptibility testing system.
    Eur J Clin Microbiol Infect Dis. 2026;45:173-183.
    PubMed         Abstract available
    
    
55. VANISHREE B, Savariraj WR, Mohan H V, Rao J, et al
    Isolation and whole-genome characterization of multidrug-resistant Acinetobacter baumannii from Indian retail meat: unveiling high-risk clones and zoonotic transmission threats via comparative genomics.
    Eur J Clin Microbiol Infect Dis. 2026;45:157-172.
    PubMed         Abstract available
    
    
56. TEBANO G, Campoli C, Meschiari M, Contadini I, et al
    Exploring heterogeneity in antibiotic choices for bloodstream infections caused by AmpC-producing enterobacterales: results from a case-vignette study.
    Eur J Clin Microbiol Infect Dis. 2026;45:125-133.
    PubMed         Abstract available
    
    
57. UZAR H, Karadogan E, Sertcelik A, Dizman GT, et al
    The impact of an institutional sepsis guideline on selecting appropriate empirical treatment in patients with carbapenem-resistant gram-negative bacilli bacteremia.
    Eur J Clin Microbiol Infect Dis. 2025 Oct 4. doi: 10.1007/s10096-025-05276.
    PubMed         Abstract available
    
    
58. PAN F, Yu F, Zhang H, Chen P, et al
    Clinical application of metagenomic next-generation sequencing (mNGS) in children with suspected bloodstream infection.
    Eur J Clin Microbiol Infect Dis. 2026;45:113-123.
    PubMed         Abstract available
    
    
59. MA D, Cai F, Zhang T
    Advances in the detection of Drug-Resistant bacteria: current trends and innovations.
    Eur J Clin Microbiol Infect Dis. 2026;45:1-17.
    PubMed         Abstract available
    
    

    
    Infect Immun

60. MIEHER JL, Schormann N, Purushotham S, Krishnan VB, et al
    The structure of Streptococcus gordonii surface protein SspB in complex with TEV peptide provides clues to oral streptococcal adherence to salivary agglutinin.
    Infect Immun. 2026 Feb 4:e0046725. doi: 10.1128/iai.00467.
    PubMed         Abstract available
    
    
61. LING J, Joyce LR, Doran KS, Hryckowian AJ, et al
    A murine model of adult gastrointestinal colonization by Group B Streptococcus.
    Infect Immun. 2026 Jan 30:e0052725. doi: 10.1128/iai.00527.
    PubMed         Abstract available
    
    

    
    J Antimicrob Chemother

62. RODRIGUEZ-VILLODRES A, Rodriguez-Lozano J, Mir-Cros A, Chueca N, et al
    Comparative activity of established versus new-generation beta-lactams against AmpC-hyperproducing clinical isolates of Enterobacter cloacae complex and Klebsiella aerogenes: a multicentre study.
    J Antimicrob Chemother. 2026;81:dkag034.
    PubMed         Abstract available
    
    
63. KARAKONSTANTIS S, Tziolos RN, Paneta M, Kritsotakis EI, et al
    Global and regional prevalence of metallo-beta-lactamases in carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2026;81:dkag037.
    PubMed         Abstract available
    
    
64. THORINGTON R, Barairo N, Peterson SW, Lourenco L, et al
    Summary of ceftriaxone-resistant Neisseria gonorrhoeae in Canada, 2017-24.
    J Antimicrob Chemother. 2026;81:dkag007.
    PubMed         Abstract available
    
    
65. SAADE A, Pilmis B, Jacquier H, Lafaurie M, et al
    Management and outcomes of Stenotrophomonas maltophilia recovered from deep-site clinical specimens: a bicentric retrospective cohort study.
    J Antimicrob Chemother. 2026;81:dkag021.
    PubMed         Abstract available
    
    
66. SHAH S, Peng L, Clarke LG, Balasubramani GK, et al
    Evaluating hypoalbuminaemia thresholds associated with delayed blood sterilization among patients receiving cefazolin or antistaphylococcal penicillins for MSSA bacteraemia.
    J Antimicrob Chemother. 2026;81:dkaf498.
    PubMed         Abstract available
    
    
67. LIU Y, Zhang SS, Chen JH, Zhu JW, et al
    Biomarker-informed PBPK modelling of meropenem in paediatric severe pneumonia: implications for target-site PK/PD.
    J Antimicrob Chemother. 2026;81:dkaf500.
    PubMed         Abstract available
    
    

    
    J Bacteriol

68. CARRIOU M, Badiou C, Soulard A, d'Enfert C, et al
    Candida albicans promotes TSST-1 production by Staphylococcus aureus through glucose depletion and relief of CcpA-mediated repression.
    J Bacteriol. 2026 Feb 5:e0042725. doi: 10.1128/jb.00427.
    PubMed         Abstract available
    
    

    
    J Biol Chem

69. FERNANDEZ-PEREZ J, de Vega S, Caaveiro JMM, Nakakido M, et al
    Development of an inhibitory monoclonal nanobody targeting Streptococcus pyogenes siderophore binding protein FtsB.
    J Biol Chem. 2026 Feb 4:111224. doi: 10.1016/j.jbc.2026.111224.
    PubMed         Abstract available
    
    
70. BHARDWAJ V, Swanson S, Florens L, Washburn MP, et al
    Histone fold domain positioning dictates cotranslational heterodimeric assembly of paralogous TAF12/TAF12L in Candida albicans.
    J Biol Chem. 2026 Feb 4:111239. doi: 10.1016/j.jbc.2026.111239.
    PubMed         Abstract available
    
    

    
    J Clin Invest

71. KARANIKA S, Wang T, Yilma A, Ruelas Castillo J, et al
    Immunotherapy targeting drug-tolerant Mycobacterium tuberculosis persisters accelerates tuberculosis cure in preclinical models.
    J Clin Invest. 2026 Feb 3:e196648. doi: 10.1172/JCI196648.
    PubMed         Abstract available
    
    
72. LI K, Yang J, Zhai X, Gou J, et al
    A protein-based pneumococcal vaccine elicits broad immunity associated with multifunctional antibody responses in humans.
    J Clin Invest. 2026;136:e196261.
    PubMed         Abstract available
    
    
73. ZHANG L, Tang Z, Zhang Y, Liu W, et al
    CARD9-dependent macrophage plasticity regulates effective fungal clearance.
    J Clin Invest. 2025;136:e188827.
    PubMed         Abstract available
    
    

    
    J Immunol

74. PI X, Pan M, Wei X, Zhang Q, et al
    Edwardsiella piscicida induces largemouth bass PINK1/Parkin-mediated mitophagy for its survival and virulence.
    J Immunol. 2026;215:vkaf277.
    PubMed         Abstract available
    
    

    
    J Infect Dis

75. DA SILVA FC, Yokoya K, Hussain R, Kamuyu G, et al
    Influence of Chlamydia trachomatis sequence variation on Pgp3 antigenicity.
    J Infect Dis. 2026 Feb 4:jiag067. doi: 10.1093.
    PubMed         Abstract available
    
    
76. RYCKMAN TS, Shrestha S, Fojo AT, Kasaie P, et al
    Modeling the impact of case finding for tuberculosis: The role of infection dynamics.
    J Infect Dis. 2026 Jan 30:jiag050. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Chem

77. XUE R, Luo C, Dou L, Yu X, et al
    Design and Synthesis of Membrane-Targeting Poly-Ruthenium Complexes Containing Quaternary Ammonium Cations with Potential Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus (MRSA).
    J Med Chem. 2026 Feb 4. doi: 10.1021/acs.jmedchem.5c02644.
    PubMed         Abstract available
    
    

    
    J Med Microbiol

78. GREITER BM, Sidorov S, Osuna E, Schalch A, et al
    Streamlining Borrelia burgdorferi cultivation using quantitative PCR screening.
    J Med Microbiol. 2026;75.
    PubMed         Abstract available
    
    
79. POH CJ, Greig DR, Rodwell EV, Jenkins C, et al
    Public health surveillance of Vibrio cholerae in travellers returning to the United Kingdom.
    J Med Microbiol. 2026;75.
    PubMed         Abstract available
    
    

    
    JAMA

80. PATEL AK, Sethi NS, Park H
    Gastric Cancer: A Review.
    JAMA. 2026;335:439-450.
    PubMed         Abstract available
    
    

    
    Pediatrics

81. KLEINERTZ A, Geoffrion T
    Primary Salmonella Osteomyelitis of the Sternum.
    Pediatrics. 2026;157:e2025073145.
    PubMed         Abstract available
    
    

    
    PLoS Biol

82. MASSOL F
    An ecological model of vaginal dysbiosis provides new research leads.
    PLoS Biol. 2026;24:e3003604.
    PubMed         Abstract available
    
    
83. KAMIYA T, Sofonea MT, France M, Tessandier N, et al
    Resource landscape shapes the composition and stability of the human vaginal microbiota.
    PLoS Biol. 2026;24:e3003575.
    PubMed         Abstract available
    
    
84. ZHOU X, Hilk A, Solis NV, Scott N, et al
    Recurrent mutations in the stress regulator Cap1 reveal a trade-off between azole resistance and oxidative stress response in Candida albicans.
    PLoS Biol. 2026;24:e3003631.
    PubMed         Abstract available
    
    
85. SON YE, Perez-Arques C, Heitman J
    Epimutations driven by RNAi or heterochromatin evoke transient antimicrobial drug resistance in pathogenic Mucor fungi.
    PLoS Biol. 2026;24:e3003598.
    PubMed         Abstract available
    
    
86. SANG Y, Ren J, Aballay A
    A gut-activated NHR-86-CYP pathway mediates the neuroprotective effects of Enterococcus faecium probiotics in a nematode model of amyotrophic lateral sclerosis.
    PLoS Biol. 2026;24:e3003627.
    PubMed         Abstract available
    
    

    
    PLoS Med

87. SCHWALB A, Dodd PJ, Rickman HM, Ugarte-Gil CA, et al
    Estimating the global burden of viable Mycobacterium tuberculosis infection: A mathematical modelling study.
    PLoS Med. 2026;23:e1004920.
    PubMed         Abstract available
    
    

    
    PLoS Negl Trop Dis

88. THONGDEE M, Chaiwattanarungruengpaisan S, Paungpin W, Sungpradit S, et al
    Pathogenic Leptospira species identified in dogs and cats during neutering in Thailand.
    PLoS Negl Trop Dis. 2026;20:e0013421.
    PubMed         Abstract available
    
    
89. SUY K, Bott S, Leng N, Sar V, et al
    Rapid diagnosis of skin and soft tissue melioidosis in children.
    PLoS Negl Trop Dis. 2026;20:e0013962.
    PubMed         Abstract available
    
    
90. ANDERSON PN, Hahn BL, Thao G, Johnson MS, et al
    In vitro and in vivo endothelial interactions of Leptospira species are markers of virulence.
    PLoS Negl Trop Dis. 2026;20:e0013939.
    PubMed         Abstract available
    
    
91. KERR CL, Patassi A, Pato PS, Guitian J, et al
    Seroprevalence and risk factors for Brucella species and Coxiella burnetii exposure in a cross-sectional serosurvey of occupationally exposed groups in peri-urban Lome, Togo.
    PLoS Negl Trop Dis. 2026;20:e0012657.
    PubMed         Abstract available
    
    

    
    PLoS One

92. LEON S, Alomeir N, Xiao J, Wu TT, et al
    Maternal and demographic factors influencing oral Candida albicans in infants: A stratified analysis using a novel partial linear semiparametric mixed-effects model.
    PLoS One. 2026;21:e0340317.
    PubMed         Abstract available
    
    
93. VON WINTERSDORFF CJH, Roelofsen M, Versteegh L, Benyahya Y, et al
    Vancomycin variable Enterococci in the Netherlands (2018-2023) and the mechanism of resistance induction.
    PLoS One. 2026;21:e0342092.
    PubMed         Abstract available
    
    
94. SHA CM, Patsakis M, Mouratidis I, Wei X, et al
    Doing more with less: Genomic quasi-G-primes differentiate septic from healthy patients.
    PLoS One. 2026;21:e0341828.
    PubMed         Abstract available
    
    
95. GEBRIE E, Baynes HW, Mengistie BA, Kassie T, et al
    Sex hormone profiles and associated factors among adult tuberculosis patients at Gondar town, northwest Ethiopia: A comparative cross-sectional study.
    PLoS One. 2026;21:e0340631.
    PubMed         Abstract available
    
    
96. ABDELSATTAR AS, Abutaleb NS, Seleem MN
    Screening a library of antibacterial compounds leads to discovery of novel inhibitors for Neisseria gonorrhoeae and Chlamydia trachomatis.
    PLoS One. 2026;21:e0340486.
    PubMed         Abstract available
    
    
97. LIBERA KC, Parmley EJ, Clow KM, Grant LE, et al
    Bridging the gap: Multi-sector perspectives on human, domestic animal, and wildlife leptospirosis in Ontario, Canada.
    PLoS One. 2026;21:e0340404.
    PubMed         Abstract available
    
    
98. PINHEIRO YT, da Silva RAR, Costa KTDS, Oliveira AGRDC, et al
    Spatial analysis of mortality due to congenital syphilis in Brazil from 2008 to 2022.
    PLoS One. 2026;21:e0326407.
    PubMed         Abstract available
    
    
99. RAHMAN K, Akter Y, Reza MS, Pappu MAA, et al
    In-silico identification of anti-cholera phytochemicals from Indian medicinal plants.
    PLoS One. 2026;21:e0342058.
    PubMed         Abstract available
    
    
100. CHOWDHURY FR, Hossain MI, Jepu TA, Saleh NUA, et al
     Streptococcus pneumoniae upregulates Toll2, Toll9, and defensin genes in Bombyx larvae infection model.
     PLoS One. 2026;21:e0341929.
     PubMed         Abstract available
     
     
101. PRAPTI BBR, Ahmmed MT, Rahman A, Chouhan CS, et al
     First report of extended-spectrum beta lactamase (ESBL) and carbapenemase-producing MDR Klebsiella pneumoniae from Fuchka.
     PLoS One. 2026;21:e0341583.
     PubMed         Abstract available
     
     
102. MA H, Tatum FM, Briggs RE, Dassanayake RP, et al
     Transcriptome profiling indicates varied gene responses to Pasteurella multocida mutant infections in cattle.
     PLoS One. 2026;21:e0341813.
     PubMed         Abstract available
     
     
103. AKTAR MT, Prapti BBR, Rahman A, Siddyqua MA, et al
     Virulent MDR Edwardsiella tarda from stinging catfish (Heteropneustes fossilis).
     PLoS One. 2026;21:e0340061.
     PubMed         Abstract available
     
     

     
     PLoS Pathog

104. CROSS T, Torres F, Nikulin N, McGee AP, et al
     Prevalence and mechanisms of high-level carbapenem antibiotic tolerance in clinical isolates of Klebsiella pneumoniae.
     PLoS Pathog. 2026;22:e1013919.
     PubMed         Abstract available
     
     
105. ZHANG C, Yang Y, Wang S, Liu Y, et al
     De novo nucleotide biosynthesis and its dynamic regulation are crucial for systemic infection by extraintestinal Escherichia coli.
     PLoS Pathog. 2026;22:e1013889.
     PubMed         Abstract available
     
     

     
     Proc Natl Acad Sci U S A

106. JOHNSON JE, Agrawal K, Al-Lamki RS, Zhang F, et al
     T cell receptors for antigen on intraepithelial cytolytic T lymphocytes in celiac disease engage enterocyte HLA-E and HLA-B.
     Proc Natl Acad Sci U S A. 2026;123:e2525433123.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum